NCT07430800 Personalized AI-Driven Models in Cognitive Behavioral Therapy for Anxiety
| NCT ID | NCT07430800 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Southern California |
| Condition | Generalized Anxiety Disorder (GAD) |
| Study Type | INTERVENTIONAL |
| Enrollment | 140 participants |
| Start Date | 2026-03-30 |
| Primary Completion | 2028-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 140 participants in total. It began in 2026-03-30 with a primary completion date of 2028-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Untreated anxiety undermines long-term physical and emotional wellbeing, especially among college students, with rates worsening since the onset of the COVID-19 pandemic. Cognitive Behavioral Therapy (CBT) is the leading evidence-based intervention for anxiety, but many students fail to complete exercises between CBT sessions, reducing its effectiveness. Socially assistive robots (SARs) help promote adherence to home-based practice in the context of elder care, social skill learning, and physical therapy, but it is unknown how SARs can enhance CBT. The specific objective of this research is to develop personalized CBT SARs that can support CBT compliance for college students with anxiety. To meet the goals of the proposed work, these studies will determine how SAR personalization based on implicit and explicit feedback can help promote greater CBT compliance and anxiety reduction outcomes for students.
Eligibility Criteria
Inclusion Criteria: * Are 18 years of age or older * Are university students * Are able to communicate in English * Have corrected-to-normal vision and hearing * Consent to have audio/video/interaction data recorded as part of the study * Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 5 or greater, indicating mild to elevated levels of self-reported symptoms of anxiety * Have a lower than minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("NO" responses to items 3, 4, 5, and 6 on C-SSRS) * Having access to home WiFi Exclusion Criteria: * Are less than 18 years of age * Are not university students * Are not able to communicate in English * Do not have corrected-to-normal vision and hearing * Do not consent to have audio/video/interaction data recorded as part of the study * Have a GAD-7 (Generalized Anxiety Disorder-7 item) score of 4 or lower. * Higher than a minimal level of suicidality risk as measured by the Columbia Suicide Severity Rating Scale (C-SSRS) during screening ("YES" responses to items 3, 4, 5, or 6 on C-SSRS) * Don't have access to home WiFi
Frequently Asked Questions
Who can join the NCT07430800 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Generalized Anxiety Disorder (GAD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07430800 currently recruiting?
Yes, NCT07430800 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Southern California to inquire about joining.
Where is the NCT07430800 trial being conducted?
This trial is being conducted at Los Angeles, United States.
Who is sponsoring the NCT07430800 clinical trial?
NCT07430800 is sponsored by University of Southern California. The trial plans to enroll 140 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.